Table 2

Best-corrected visual acuity (BCVA) at presentation and at final follow-up, Hughes-Roper-Hall (H-R-H) grade, surgical intervention and corneal sequelae for all patients, and whether patients were lost to follow-up

Patient	BCVA at presentation	BCVA at final follow-up	H-R-H grade	Surgical intervention	Long-term complications	Lost to follow-up?
1	6/9	6/4	3	–		No
2	6/18	6/18	3	–	KS, CCS	No
3	6/24	6/6	3	–		No
4	6/6	6/9	3	–	CCS	No
5	6/12	6/5	3	–		DNA at 1/52
6	6/6	6/9	3	–	KS	No
7	6/24	Unknown	3	–		DNA at 1/52
8	6/9	6/12	4	–		DNA at 1/12
9	6/9	6/5	3	–		No
10	6/24	6/6	4	–	KS, CCS, CP	No
11	6/9	6/18	4	–		DNA at 1/12
12	6/18	6/6	3	–	CCS	No
13	6/12	6/12	3	–		DNA at 1/12
14	6/36	6/9	4	–		DNA at 1/12
15	6/24	6/12	4	–		DNA at 1/12
16	6/18	6/9	3	–	KS, CCS	No
17	CF	HM	4	–	PED	No
18	6/18	6/12	3	–		No
19	4/60	3/60	3	–		DNA at 3/12
20	6/12	HM	3	–	KS, PED, CCS	DNA at 12/12
21	6/36	HM	4	–	KS, PED, MK, CCS, CP, Ent	No
22	6/36	6/6	3	–		DNA at 1/12
23	6/12	6/5	3	–		No
24	3/60	6/12	4	–		No
25	6/18	6/9	3	AMG, LSC, PK, Phaco	PED, CCS, Cat	No

AMG, amniotic membrane graft; CCS, central corneal scar; CF, counting fingers; CP, central pannus; DNA, did not attend follow-up; Ent, entropion; HM, hand movements; KS, keratoconjunctivitis sicca; LSC, limbal stem cell graft; MK, microbial keratitis; PED, persistent epithelial defect; Phaco, phacoemulsification and intra-ocular lens insertion; PK, penetrating keratoplasty.